Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
---|
01/19/2005 | CN1568330A Glycosylphosphatidylinositol containing polypeptides |
01/19/2005 | CN1568325A Cross-linked glycopeptide-cephalosporin antibiotics |
01/19/2005 | CN1568320A 异羟肟酸衍生物 Hydroxamic acid derivatives |
01/19/2005 | CN1568316A Activator for peroxisome proliferator-responsive receptor delta |
01/19/2005 | CN1568310A Heterocyclic inhibitors of glycogen synthase kinase GSK-3 |
01/19/2005 | CN1568308A Salts of guanidine derivatives and pharmaceutical preparations consisting thereof |
01/19/2005 | CN1568207A 2-amino-6-(2, 4, 5-substituted-phenyl)-pyridines |
01/19/2005 | CN1568198A Use of cd23 antagonists for the treatment of neoplastic disorders |
01/19/2005 | CN1568197A Composite superimmunogen for bi-functional vaccine use for the treatment of illnesses associated with a stromal tissue disorder |
01/19/2005 | CN1568181A Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles |
01/19/2005 | CN1568177A Anti-microbial composition comprising a metal ion chelating agent |
01/19/2005 | CN1566335A Mass preparation of SARS virus capable of meeting the production of inactivated vaccine and inactivation method |
01/19/2005 | CN1566334A Novel reovirus, its antibody and vaccine and use thereof |
01/19/2005 | CN1566158A Recombinant vaccine for prevention and treatment of SARS virus |
01/19/2005 | CN1566155A Anti-SARS monoclonal antibody, encoding sequence and application thereof |
01/19/2005 | CN1566154A Novel hepatocyte growth factor, preparing process and application thereof |
01/19/2005 | CN1566153A Method for separating and extracting saccule peptides from saccules rotundus of rabbits |
01/19/2005 | CN1566152A Immunoreactive peptide Trpi possessing antibacterial action |
01/19/2005 | CN1566144A Functional protein in SARS coronavirus |
01/19/2005 | CN1566143A Antigenic determinant of SARS coronavirus nucleocapsid protein and application thereof |
01/19/2005 | CN1566142A Polypeptide drug for inhibiting SARS coronavirus from infecting host cell |
01/19/2005 | CN1566136A Pasqueflower notoginsenosides and extraction method, medicinal uses and pharmaceutical preparation thereof |
01/19/2005 | CN1566134A Non-structural protein gene of coronavirus and use thereof |
01/19/2005 | CN1566131A Small interference RNA molecule SiRNA capable of attacking human hepatitis B virus and application thereof |
01/19/2005 | CN1566130A Nucleoside analogue lipid derivative and salt thereof |
01/19/2005 | CN1566129A 4'-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives |
01/19/2005 | CN1566118A Antiviral activity possessed compound and preparation method thereof |
01/19/2005 | CN1566094A Antiviral activity possessed compound |
01/19/2005 | CN1565631A Usage of fused protein of TNF receptor and globin in acute lung injury treating medicine |
01/19/2005 | CN1565630A Novel pestilence DNA vaccine and its construction and application |
01/19/2005 | CN1565629A Novel pestilence DNA vaccine and its usage |
01/19/2005 | CN1565628A Usage of reovirus genome and its coding protein in the SARS related research |
01/19/2005 | CN1565627A Hemoglobin alpha chain peptide fragments useful for inhibiting stem cell proliferation |
01/19/2005 | CN1565620A Usage of IL-1 acceptor antagon in the treatment of SARS |
01/19/2005 | CN1565614A Externally applied medicinal composition for resisting inflammation and repressing and killing bacteria and preparing method |
01/19/2005 | CN1565607A Chinese drug composition for treating viral infection of upper respiratory tract and preparing process thereof |
01/19/2005 | CN1565595A Chinese herbal medicine extracts with antivirus activity and preparing method thereof |
01/19/2005 | CN1565591A Preparation and usage of |
01/19/2005 | CN1565581A Immune function regulating antibiotic and anti-inflammatory drug with broad spectrum |
01/19/2005 | CN1565572A SARS treating medicine |
01/19/2005 | CN1565567A Antivirus medicine and its preparing method |
01/19/2005 | CN1565565A Chinese drugs for treating Hepatitis B and AIDS |
01/19/2005 | CN1565559A Medicine for treating cold and cough |
01/19/2005 | CN1565544A Medicine for treating cold disease |
01/19/2005 | CN1565534A Chinese traditional medicinal combination for treating putrescence of malignant disease |
01/19/2005 | CN1565521A Cold treating pills |
01/19/2005 | CN1565517A Preparing method of nanometer level high purity freeze dried powder of aloe and its preparation |
01/19/2005 | CN1565512A Blood sugar decreasing Chinese herbal medicine for treating SARS patients with diabetes complication |
01/19/2005 | CN1565511A Chinese medicine oral liquid for preventing and treating virulent diarrhea due to the incursion of SARS virus to stomach and intestine |
01/19/2005 | CN1565510A Incense or incense holding box for preventing SARS and other epidemic disease |
01/19/2005 | CN1565490A Chinese herbal medicine prescription for preventing and treating plague of birds and livestock |
01/19/2005 | CN1565475A Pertinent cure, immunity and prevention for atypical pneumonia, all kinds of virus infection of respiratory tract |
01/19/2005 | CN1565474A Biochemical nucleic acid fulvic acid oral liquid production method |
01/19/2005 | CN1565463A Hepatitis B therapeutic medicine |
01/19/2005 | CN1565459A Dermatopathy therapeutic medicine compositions and its preparation method |
01/19/2005 | CN1565457A Beta- lactamase suppressing antibacterial compound drugs |
01/19/2005 | CN1565456A Cefepime compound antibacterial drugs |
01/19/2005 | CN1565455A Antibiotics compositions for curing broad spectrum beta-lactamase bacteria infection |
01/19/2005 | CN1565447A Drug for prevention and cure of bacterial and viral infection , atypical pneumonia |
01/19/2005 | CN1565446A Freeze-drying fluconazole injection and its preparation method |
01/19/2005 | CN1565442A Use of racemoid nor-poon essence A in preparation of AIDS drug |
01/19/2005 | CN1565440A Silymarin Methylglucamine clathrate compound and its preparation method |
01/19/2005 | CN1565431A 3, 4-dihydroxylbenzaldehyde pharmaceutical use |
01/19/2005 | CN1565430A Allicin cyclodextrin clathrate compound, formulation and its preparation method |
01/19/2005 | CN1565422A AIDS drug didanosine granula composition and its preparation method |
01/19/2005 | CN1185254C First hypervariable region antigen of hepatitis C and fusion antigen |
01/19/2005 | CN1185232C Inhibitors of alpha L beta 2 mediated cell adhesion |
01/19/2005 | CN1185231C Meadowrueleaf corydalis general alkaloid and its prepn and application |
01/19/2005 | CN1185230C N-substituted carbamoyloxyalkyl-azolium derivs. |
01/19/2005 | CN1185227C Novel compounds |
01/19/2005 | CN1185223C Novel Compounds and methods for synthesis and therapy |
01/19/2005 | CN1185215C Substituted glutarimides and use as IL-12 production inhibitors thereof |
01/19/2005 | CN1185211C Benzamide derivatives for the treatment of diseases resulted from cytokines |
01/19/2005 | CN1185012C DNA vaccine pVFS of SARS virus |
01/19/2005 | CN1185011C DNA vaccine pVPS of SARS virus |
01/19/2005 | CN1185005C Medicine for treating inflammation and its preparation method |
01/19/2005 | CN1184986C Spray for preventing and treating cold |
01/19/2005 | CN1184979C Medicine for treating diabetes and phthisis |
01/19/2005 | CN1184972C Composite preparation of sodium para-aminosallicylate and trimethoprim |
01/19/2005 | CN1184968C Antibiotic compositions for treatment of the eye, ear and nose |
01/19/2005 | CN1184964C Use of carbonylamino derivatives against CNS disorders |
01/18/2005 | US6845328 Detection of enzyme modulators; obtain three dimensional structure of enzyme, design modulator to bind active site, incubate with test modulator, monitor adjustment in enzyme activity |
01/18/2005 | US6844456 Administering steriods (e.g. estrogens), wherein a non-fused polycyclic, hydrophobic substituent such as adamantanyl is attached to the hydroxy-substituted A-ring thereof |
01/18/2005 | US6844363 Storage stability; drugs; influenza therapy |
01/18/2005 | US6844359 As inhibitors of tumor necrosis factor; for therapy of cachexia, arthritis, rheumatoid arthritis, osteoarthritis, reperfusion injury, congestive heart failure, Crohn's disease, ulcerative colitis, systemic lupus erythrematosis |
01/18/2005 | US6844343 N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent |
01/18/2005 | US6844342 Heterocyclic substituted 2-methyl-benzimidazole antiviral agents |
01/18/2005 | US6844340 Tricyclic 2-pyrimidone compounds useful as HIV reverse transcriptase inhibitors |
01/18/2005 | US6844335 2-amino-3-(alkyl)-pyrimidone derivatives as GSK3.β.inhibitors |
01/18/2005 | US6844329 Synthetic oligo- and polysaccharides exhibiting at least one covalent bond with biotin or a biotin derivative and having the anticoagulant and antithrombotic pharmacological activities of heparin |
01/18/2005 | US6844327 Gene therapy approaches to supply apolipoprotein A-I agonists and their use to treat dyslipidemic disorders |
01/18/2005 | US6844306 Water-soluble, chlorhexidine-containing compositions and use thereof |
01/18/2005 | US6844180 Nucleotide sequences for use in the treatment of viral diseases, hypertension and coagulation defects |
01/18/2005 | US6844179 Protein and DNA thereof |
01/18/2005 | US6844173 Strain of Streptomyces griseus |
01/18/2005 | US6844012 Suppressing cytokine secretion with such as sodium selenite |
01/18/2005 | US6843999 Streptococcal ABC transporter protein |
01/18/2005 | US6843993 Anti-microbial-adhesion fraction derived from vaccinium |
01/18/2005 | US6843992 Immuno-reactive peptide CTL epitopes of human cytomegalovirus |
01/18/2005 | US6843991 Use of the M3 protein of MHV68 to block binding of a chemokine to its receptor |